AbcuroListed
abcuro.combiotech_life_sciences
Abcuro is developing breakthrough therapies for autoimmune diseases and cancer, focusing on selective targeting of highly cytotoxic T cells. Their lead product candidate, ulviprub…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Abcuro is developing breakthrough therapies for autoimmune diseases and cancer, focusing on selective targeting of highly cytotoxic T cells. Their lead product candidate, ulviprub…
AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies for cancer treatment.
Aetion provides real-world evidence (RWE) solutions and analytics for the healthcare industry, focusing on transforming real-world data into decision-grade evidence.
Aliada Therapeutics is a neuroscience-focused company working towards overcoming the delivery hurdle in large molecule drug development. Aliada is advancing a generation of CNS th…
Atalanta Therapeutics is a biotechnology company pioneering RNA interference (RNAi) for the treatment of intractable neurological diseases, utilizing its proprietary platform of d…
Attovia Therapeutics is a clinical-stage biopharmaceutical company focused on immune-mediated diseases, developing next-generation biologic therapies using its proprietary ATTOBOD…
Avilar Therapeutics is pioneering the discovery and development of extracellular protein degraders, focusing on a new class of therapeutics called ATACs (ASGPR Targeting Chimeras)…
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases. The company focuses on creating…
Bluebird Bio, now rebranded as Genetix Biotherapeutics, focuses on delivering transformative genetic therapies for patients with rare genetic diseases, including sickle cell disea…
Carbon Health offers modern primary and urgent care services, accepting all major insurance providers. They provide same-day appointments and utilize technology to improve healthc…
Character Bio is a precision medicine company unlocking the patterns of progressive polygenic diseases, with an initial focus on macular degeneration.
Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with…
Common Sensing is a VC-backed seed-stage startup based in Cambridge, MA that creates hardware and software medical device solutions for diabetes care that foster education and com…
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines, focusing on improving tolerability, efficacy, and accessibility of va…
Curisium is a healthcare technology and services company that offers contracting solutions designed to enable scalable, data-driven agreements among payers, pharmaceutical manufac…
Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to restore the brain to a healthier state, enabling patients to live their best lives.
Eligo Bioscience focuses on in vivo gene editing to treat diseases linked to microbiomes. The company targets conditions with high unmet medical needs.
Empatica provides a health monitoring platform that combines wearable technology and digital biomarkers for clinical trials and academic research, focusing on conditions such as e…
Epicrispr Biotechnologies is developing therapies to dynamically control gene expression and treat complex diseases using epigenetic editing.
Escient Pharmaceuticals is a clinical-stage biotechnology company focused on developing GPCR-targeted therapies for neurosensory-inflammatory disorders. The company is advancing f…
Evidation connects directly with people, providing real-world data to power faster decisions and improve health in everyday life.
Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021. The company aims to create o…
Expedition Therapeutics is a biotech company developing treatments for inflammatory and respiratory diseases, including COPD. The company's lead drug, EXPD-101, targets neutrophil…
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patien…
Fulcrum Therapeutics focuses on developing small molecules to improve the lives of patients with genetically defined rare diseases, particularly in areas of high unmet medical nee…
GlycoMimetics, Inc. is a biotechnology company focused on developing small molecule drugs, specializing in glycomimetics technology for cancer and blood disorders.
Glycomine is developing replacement therapies for rare genetic diseases with the goal of delivering meaningful improvements in quality of life for patients, caregivers, and famili…
Granite Bio is a biotechnology company developing first-in-class antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases.
i2O Therapeutics focuses on developing GLP-1 combinations for obesity and cardio-renal-metabolic diseases, with a pipeline that includes long-acting GLP-1 receptor agonists and ot…
Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial fo…
Imbria Pharmaceuticals is a clinical-stage company transforming the treatment of cardiovascular disease by targeting cardiac energy metabolism. The company’s focus is ninerafaxsta…
Details are not available yet. The company remains listed.
Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Their lead product candidate is INZ-701, an e…
Juno Therapeutics is now part of Bristol Myers Squibb, a global biopharmaceutical company focused on cancer care. The company develops new medicines through innovative research.
Laronde is a biotech company developing Endless RNA, a programmable RNA platform. It merged with Senda Biosciences to form Sail Biomedicines in 2023. Sail Biomedicines continues t…
Longhorn Pharmaceuticals is a biopharmaceutical company focused on developing vaccines, monoclonal antibodies, and diagnostics for infectious and inflammatory diseases. It address…
Refaccionaria Moderna is a leading automotive parts supplier in northern Mexico, with over 70 years in the market and multiple branches strategically located in metropolitan Monte…
Neurogene is a clinical-stage biotechnology company focused on developing life-changing genetic medicines for people and their families impacted by devastating neurological diseas…
Passage Bio is a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases through the development of innovative gene the…
Tidepool is a nonprofit organization focused on improving diabetes management through accessible and actionable data. They provide software solutions that integrate data from vari…
QuantHealth is the global leader in AI-driven, clinical trial simulations, helping biopharma companies optimize and de-risk their clinical trials before patient enrollment.
Diagonal Therapeutics is a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, focusing on her…
BranchLab is an AI-driven platform designed to enhance healthcare commercialization by predicting health outcomes using demographic data, ensuring compliance while improving perfo…